Congo-Brazzaville (OAPI) drug patents, generic entry dates and freedom-to-operate

Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Comoros, Congo Brazzaville, Côte d'Ivoire, Equatorial Guinea, Gabon, Guinea, Guinea-Bissau, Mali, Mauritania, Niger, Senegal, Togo

Drug Patents in African Intellectual Property Organization (OAPI) and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Document Number	Estimated Expiration	Equivalent US Patent	US Expiry Date	Generic Name	US Applicant	US Tradename
10319	➤ Sign Up	5635485	Apr 1, 2018	telithromycin	Sanofi Aventis Us	KETEK
11285	➤ Sign Up	6039974	Jul 31, 2018	fexofenadine hydrochloride; pseudoephedrine hydrochloride	Sanofi Aventis Us	ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
10475	➤ Sign Up	6107458	Mar 16, 2019	micafungin sodium	Astellas	MYCAMINE
11350	➤ Sign Up	6124363	Oct 9, 2018	dofetilide	Pfizer	TIKOSYN
11064	➤ Sign Up	6150366	May 27, 2019	ziprasidone hydrochloride	Pfizer	GEODON
11064	➤ Sign Up	6150366	May 27, 2019	ziprasidone hydrochloride	Pfizer Inc	GEODON
Document Number	Estimated Expiration	Equivalent US Patent	US Expiry Date	Generic Name	US Applicant	US Tradename

Congo-Brazzaville (OAPI) Drug Patents

Benin, Burkina Faso, Cameroon, Central African Republic, Chad, Comoros, Congo Brazzaville, Côte d'Ivoire, Equatorial Guinea, Gabon, Guinea, Guinea-Bissau, Mali, Mauritania, Niger, Senegal, Togo

Drug Patents in African Intellectual Property Organization (OAPI) and US Equivalents

For more information try a trial or see the plans and pricing